生物活性 | |||
---|---|---|---|
描述 | GNE-9815 is a potent, highly selective, pan-RAF inhibitor with excellent oral bioavailability. It shows Ki values of 0.062 nM for CRAF and 0.19 nM for BRAF. GNE-9815, in combination with the MEK inhibitor Cobimetinib, effectively modulates the MAPK pathway, making it suitable for research on KRAS mutant cancers[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.20mL 0.44mL 0.22mL |
10.98mL 2.20mL 1.10mL |
21.95mL 4.39mL 2.20mL |
参考文献 |
---|